GLP-1 receptor agonists (GLP-1 RAs) are widely recognised for their role in weight loss and metabolic regulation. New evidence now indicates they may also help reduce persistent food cravings and “food noise,” supporting more sustainable and holistic lifestyle changes.
Understanding food noise
Food noise refers to persistent, intrusive thoughts about food that individuals perceive as unwanted or distressing. These thoughts can contribute to social, mental, or physical challenges.
While often confused with food cravings, food noise is distinct. Cravings are typically occasional, intense urges for specific foods — often high-calorie or energy-dense items. Food noise, in contrast, is constant and generalised. It involves ongoing preoccupation with eating — including repeated thoughts about what to eat, portion sizes, calorie intake, nutritional value, and meal timing.
Individuals experiencing food noise may frequently question themselves: “Did I eat enough?” or “Was that too many calories?” These intrusive thoughts can be triggered by external factors such as dieting, the sight or smell of food, or advertisements, as well as internal cues like hunger. However, food noise can also arise without clear triggers, making it particularly disruptive.
The role of GLP-1 therapies
Certain GLP-1–based therapies have been shown to significantly reduce food noise.
Citing findings from the US-based INFORM survey, Dr. Shashank R. Joshi, Consultant Endocrinologist at Lilavati Hospital, Sir HN Reliance Foundation Hospital (RFH), and Joshi Clinic in Mumbai, said that among 550 individuals using GLP-1 medications for weight management:
- 46% reported a reduction in constant thoughts about food
- 64% experienced improvements in mental health
- 80% adopted healthier lifestyle habits
These findings suggest that GLP-1 RAs may influence not only appetite regulation but also behavioural patterns and psychological well-being.
Redefining obesity care
Food noise is increasingly being recognised as a meaningful therapeutic target in obesity management. While further research is required, emerging data point to a broader role for GLP-1 receptor agonists beyond weight reduction alone.
By helping to regulate appetite, reduce intrusive food-related thoughts, and improve mental clarity, these therapies may enable individuals living with overweight or obesity to build healthier, more balanced daily routines.
Individuals interested in GLP-1 RAs should consult a registered healthcare professional to determine whether this treatment option aligns with their specific health goals.
For people living with overweight and obesity. Weight management outcomes vary depending on individual treatment journeys and should always be pursued under medical supervision.
